ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 132 filers reported holding ENANTA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.88 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $115,388 | -64.3% | 10,386 | +45.4% | 0.00% | – |
Q4 2022 | $323,620 | +7.2% | 7,144 | +24.4% | 0.00% | – |
Q3 2022 | $302,000 | -68.2% | 5,742 | -71.2% | 0.00% | -100.0% |
Q2 2022 | $950,000 | -35.4% | 19,972 | -1.7% | 0.00% | -50.0% |
Q1 2022 | $1,471,000 | +18.1% | 20,324 | +17.7% | 0.00% | +100.0% |
Q4 2021 | $1,246,000 | +83.0% | 17,269 | +45.1% | 0.00% | 0.0% |
Q3 2021 | $681,000 | +28.7% | 11,904 | -0.0% | 0.00% | 0.0% |
Q2 2021 | $529,000 | +142.7% | 11,906 | +126.0% | 0.00% | – |
Q4 2020 | $218,000 | -8.4% | 5,269 | +0.6% | 0.00% | – |
Q3 2020 | $238,000 | -76.6% | 5,236 | -74.2% | 0.00% | -100.0% |
Q2 2020 | $1,019,000 | +11.5% | 20,295 | +37.7% | 0.00% | 0.0% |
Q4 2019 | $914,000 | – | 14,740 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Krensavage Asset Management, LLC | 858,811 | $36,156,000 | 10.56% |
Fairmount Funds Management LLC | 150,433 | $6,333,000 | 2.26% |
ARMISTICE CAPITAL, LLC | 1,356,000 | $57,088,000 | 1.94% |
FARALLON CAPITAL MANAGEMENT LLC | 1,775,000 | $74,728,000 | 0.45% |
Virtus ETF Advisers LLC | 14,321 | $603,000 | 0.25% |
Granahan Investment Management | 231,071 | $9,728,000 | 0.22% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 248,320 | $10,454,000 | 0.09% |
ACADIAN ASSET MANAGEMENT LLC | 467,514 | $19,684,000 | 0.08% |
VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. | 126 | $5,000 | 0.08% |
AIGEN INVESTMENT MANAGEMENT, LP | 12,854 | $541,000 | 0.07% |